Shalby Limited (SHALBY.BO)
- Previous Close
283.85 - Open
288.60 - Bid 278.00 x --
- Ask --
- Day's Range
277.25 - 288.60 - 52 Week Range
134.80 - 333.85 - Volume
13,722 - Avg. Volume
24,950 - Market Cap (intraday)
29.949B - Beta (5Y Monthly) 1.04
- PE Ratio (TTM)
36.91 - EPS (TTM)
7.57 - Earnings Date May 13, 2024 - May 17, 2024
- Forward Dividend & Yield 1.20 (0.43%)
- Ex-Dividend Date Aug 8, 2023
- 1y Target Est
264.00
Shalby Limited operates multi-specialty hospitals primarily in India, North America, Japan, and Indonesia. The company offers arthroscopy, arthroplasty, cardiology, cardiothoracic and vascular surgery, cosmetic and aesthetic, dental cosmetic and implantology, emergency medicine, endocrinology, endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, general medicine and surgery, hair transplant, liver transplant, dermatology, psychiatry, urology, anesthesia, and hip and knee joint replacement services. It also provides infectious disease, infertility and IVF, intensive and critical care, maxillofacial surgery, nephrology, neurosurgery, neurology, obesity surgery, obstetrics and gynecology, oncology, oncosurgery, ophthalmology and glaucoma, orthopedic and trauma, pediatric orthopedic, pathology and microbiology, pediatrics and neonatology, plastic surgery, pulmonology and chest, radiology and imaging, rheumatology, trauma, spine surgery, and urosurgery services, as well as organ donation. In addition, it offers outpatient services, as well as provides educational programs for paramedical students and other healthcare professionals; and homecare services, such as ICU at home, diagnostics, attendants, doctor visit, nursing care, physiotherapy, pharmacy, and medical equipment. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is headquartered in Ahmedabad, India.
www.shalby.org2,678
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: SHALBY.BO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SHALBY.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SHALBY.BO
Valuation Measures
Market Cap
29.95B
Enterprise Value
29.57B
Trailing P/E
36.91
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.38
Price/Book (mrq)
3.11
Enterprise Value/Revenue
3.33
Enterprise Value/EBITDA
15.87
Financial Highlights
Profitability and Income Statement
Profit Margin
9.16%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
8.89B
Net Income Avi to Common (ttm)
813.76M
Diluted EPS (ttm)
7.57
Balance Sheet and Cash Flow
Total Cash (mrq)
1.98B
Total Debt/Equity (mrq)
16.69%
Levered Free Cash Flow (ttm)
--
Research Analysis: SHALBY.BO
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: SHALBY.BO
SHALBY.BO does not have Company Insights